Home > Leon Kircik, AAD VMX 2021: Roflumilast Foam in Scalp and Body Psoriasis
Psoriasis

Leon Kircik, AAD VMX 2021: Roflumilast Foam in Scalp and Body Psoriasis

Published Online: July 19th 2021

Prof. Leon Kircik (Icahn School of Medicine at Mount Sinai, New York, NY, USA) kindly took the time to speak with us about the results from the recent phase 2b study investigating roflumilast foam in the treatment of scalp and body psoriasis.

His abstract entitled ‘Once-daily Roflumilast Foam 0.3% for Scalp and Body Psoriasis: A Randomized, Double-blind, Vehicle-controlled Phase 2b Study’ was presented at AAD VMX, 23-25 April.

Questions

  1. Can you give us a brief overview of scalp psoriasis, its disease burden and the unmet needs in its treatment? (0:20)
  2. Could you tell us a little about roflumilast and the aim of your study? (1:10)
  3. Could you tell us about the design and patient population enrolled in your phase 2b study? (1:33)
  4. What were the key clinical endpoints measured in the study? (2:17)
  5. Could you briefly summarize the overall results? (2:28)

Disclosures: Prof. Leon Kircik is a speaker for Galderman, Genetech, Johnson & Johnson, Leo Pharma, 3M Pharmaceuticals, Onset Dermatologics, Pharmaderm, Merck Serano, SkinMedica, Stiefel a GSK company, Triax Pharmaceuticals, Valeant Pharmaceuticals, Warner Chilcott; serves on an advisory board for Galderma, Genetech, Intendis, Johnson & Johnson, NanoBio Corporation, Promius Pharma, LLC, SkinMedica, Stiefel a GSK company, Valeant Pharmaceuticals, Warner Chilcott; is an investigator for Ferndale Laboratories, Galderman, Genetech, GlaxoSmithKline, Healthpoint, Intendis, Johnson & Johnson, Leo Pharma, 3M Pharmaceuticals, Medicis Pharmaceutical Corporation, NanoBio Corporation, Novartis Pharmaceuticals, Nucryst, Obagi Medical Products, Onset Dermatologics, Orthro Dermatologics, Promius Pharma, LLC, QLT Inc, Pharmaderm, Pfizer, SkinMedica, Stiefel a GSK company, TolerRx, Triax Pharmaceuticals, LLC, Valeant Pharmaceuticals, Warner Chilcott; is a consultant for Galderma Laboratories, Genetech, Intendis, Johnson & Johnson, Leo Pharma, Medical International Technologies, Merck & Co, Merz Pharmaceuticals, Novartis, Promius Pharma, PuraCap Pharmacetical, SkinMedica, Stiefel a GSK company, Triax Pharmaceuticals, Valeant Pharmaceutical.

Support: Interview and filming supported by Touch Medical Media. Interview conducted by Gina Furnival.

Filmed in coverage of the AAD VMX 2021.

Share this Video
Related Videos In Psoriasis
  • Copied to clipboard!
    accredited arrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greenarrow-right-greyarrow-right-orangearrow-right-whitearrow-right-bluearrow-up-orangeavatarcalendarchevron-down consultant-pathologist-nurseconsultant-pathologistcrosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmdt_iconmenumore_dots nurse-consultantpadlock patient-advocate-pathologistpatient-consultantpatientperson pharmacist-nurseplay_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share single-doctor social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-whiteticktimetranscriptup-arrowwebinar Department Location NEW TMM Corporate Services Icons-07NEW TMM Corporate Services Icons-08NEW TMM Corporate Services Icons-09NEW TMM Corporate Services Icons-10NEW TMM Corporate Services Icons-11NEW TMM Corporate Services Icons-12Salary £ TMM-Corp-Site-Icons-01TMM-Corp-Site-Icons-02TMM-Corp-Site-Icons-03TMM-Corp-Site-Icons-04TMM-Corp-Site-Icons-05TMM-Corp-Site-Icons-06TMM-Corp-Site-Icons-07TMM-Corp-Site-Icons-08TMM-Corp-Site-Icons-09TMM-Corp-Site-Icons-10TMM-Corp-Site-Icons-11TMM-Corp-Site-Icons-12TMM-Corp-Site-Icons-13TMM-Corp-Site-Icons-14TMM-Corp-Site-Icons-15TMM-Corp-Site-Icons-16TMM-Corp-Site-Icons-17TMM-Corp-Site-Icons-18TMM-Corp-Site-Icons-19TMM-Corp-Site-Icons-20TMM-Corp-Site-Icons-21TMM-Corp-Site-Icons-22TMM-Corp-Site-Icons-23TMM-Corp-Site-Icons-24TMM-Corp-Site-Icons-25TMM-Corp-Site-Icons-26TMM-Corp-Site-Icons-27TMM-Corp-Site-Icons-28TMM-Corp-Site-Icons-29TMM-Corp-Site-Icons-30TMM-Corp-Site-Icons-31TMM-Corp-Site-Icons-32TMM-Corp-Site-Icons-33TMM-Corp-Site-Icons-34TMM-Corp-Site-Icons-35TMM-Corp-Site-Icons-36TMM-Corp-Site-Icons-37TMM-Corp-Site-Icons-38TMM-Corp-Site-Icons-39TMM-Corp-Site-Icons-40TMM-Corp-Site-Icons-41TMM-Corp-Site-Icons-42TMM-Corp-Site-Icons-43TMM-Corp-Site-Icons-44TMM-Corp-Site-Icons-45TMM-Corp-Site-Icons-46TMM-Corp-Site-Icons-47TMM-Corp-Site-Icons-48TMM-Corp-Site-Icons-49TMM-Corp-Site-Icons-50TMM-Corp-Site-Icons-51TMM-Corp-Site-Icons-52TMM-Corp-Site-Icons-53TMM-Corp-Site-Icons-54TMM-Corp-Site-Icons-55TMM-Corp-Site-Icons-56TMM-Corp-Site-Icons-57TMM-Corp-Site-Icons-58TMM-Corp-Site-Icons-59TMM-Corp-Site-Icons-60TMM-Corp-Site-Icons-61TMM-Corp-Site-Icons-62TMM-Corp-Site-Icons-63TMM-Corp-Site-Icons-64TMM-Corp-Site-Icons-65TMM-Corp-Site-Icons-66TMM-Corp-Site-Icons-67TMM-Corp-Site-Icons-68TMM-Corp-Site-Icons-69TMM-Corp-Site-Icons-70TMM-Corp-Site-Icons-71TMM-Corp-Site-Icons-72